Go Pro
NASDAQ:BNBX

Applied Dna Sciences Q4 2025 Earnings Report

Applied Dna Sciences logo
$0.13 -0.01 (-9.34%)
As of 12:48 PM Eastern

Applied Dna Sciences EPS Results

Actual EPS
$122.52
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Applied Dna Sciences Revenue Results

Actual Revenue
$0.20 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Applied Dna Sciences Announcement Details

Quarter
Q4 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Applied Dna Sciences Earnings Headlines

Head-To-Head Comparison: Applied Dna Sciences (BNBX) vs. Its Rivals
Comparing Applied Dna Sciences (BNBX) & Its Rivals
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
Comparing Applied Dna Sciences (BNBX) & The Competition
Contrasting Applied Dna Sciences (NASDAQ:BNBX) & Neurogene (NASDAQ:NGNE)
Head-To-Head Comparison: Applied Dna Sciences (BNBX) & Its Peers
See More Applied Dna Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Applied Dna Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Applied Dna Sciences and other key companies, straight to your email.

About Applied Dna Sciences

Applied Dna Sciences (NASDAQ:BNBX), Inc. is a biotechnology company that develops and commercializes DNA-based technologies for molecular diagnostics, biopharmaceutical manufacturing and supply-chain security. Its platform uses synthetic and naturally occurring DNA sequences as tools for identification, authentication, traceability and biological production.

The company’s offerings have included the CertainT platform for textile and supply-chain traceability, SigNature molecular tags for product authentication and anti-counterfeiting, and DNA-based solutions used in life sciences research and manufacturing. Applied DNA has also developed molecular diagnostic products and technologies intended to support pathogen detection and other clinical applications.

Founded in 2002 and headquartered in Stony Brook, New York, Applied DNA Sciences serves customers in the United States and international markets through applications spanning textiles, consumer products, industrial materials, agriculture and healthcare. The company has historically been led by founder James A. Hayward, who has served as chairman and chief executive officer.

View Applied Dna Sciences Profile